Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer
Pei‐Chih Lee(The University of Texas MD Anderson Cancer Center), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center), Yueh‐Fu Fang(The University of Texas MD Anderson Cancer Center), Shu‐Fen Chiang(China Medical University), Xuan Hong(Harbin Medical University), Wenhao Yang(China Medical University), Zhengyu Zha(Sichuan University), Chih‐Yen Tu(National Chung Hsing University), Jennifer L. Hsu(The University of Texas MD Anderson Cancer Center), Kwok‐Kin Wong(Brigham and Women's Hospital), Chun‐Te Chen(Leo Pharma (Australia)), Bingliang Fang(The University of Texas MD Anderson Cancer Center), Rong Deng(Sun Yat-sen University), Yi‐Hsin Elsa Hsu(The University of Texas MD Anderson Cancer Center), Wei‐Jan Wang(China Medical University), Chih‐Wei Wang(Chang Gung University), Katsuya Nakai(The University of Texas MD Anderson Cancer Center), Hirohito Yamaguchi(Qatar Foundation), Yan Wang(The University of Texas MD Anderson Cancer Center), Li Wang(The University of Texas MD Anderson Cancer Center), Ran Zhang(Buck Institute for Research on Aging), Ting Chen(China Medical University), Lei Nie(The University of Texas MD Anderson Cancer Center), Chia‐Hung Chen(The University of Texas MD Anderson Cancer Center), Jun Tang(Hubei University of Medicine), Junwei Hou(Institute of Microbiology), Han-Pin Kuo(Chang Gung University), Yongkun Wei(The University of Texas MD Anderson Cancer Center), Tai-Jan Chiu(The University of Texas MD Anderson Cancer Center), Tse-Ching Chen(Chang Gung University), Longfei Huo(The University of Texas MD Anderson Cancer Center), Weiya Xia(The University of Texas MD Anderson Cancer Center), Baozhen Ke(The University of Texas MD Anderson Cancer Center)
Cited by 71
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
|Nature Communications|2016|1.1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
False-Positive Plasma Genotyping Due to Clonal Hematopoiesis
|Clinical Cancer Research|2018|445
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
|Nature Communications|2018|427